Middle East Cancer Chemotherapy Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Middle East Cancer Chemotherapy Market

Middle East Cancer Chemotherapy Market Outlook (2021–2031)

The Middle East Cancer Chemotherapy Market size is expected to reach US$ 772.1 million by 2031 from US$ 439.5 million in 2024. The market is estimated to record a CAGR of 8.4% from 2025 to 2031.

Report Coverage
  • Therapy Type: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Therapy Type
  • Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
  • End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 439.5 Mn Market size in 2024
US$ 772.1 Mn Market Size by 2031
8.4% CAGR, 2025 - 2031
2025-2031 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East Cancer Chemotherapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East Cancer Chemotherapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East Cancer Chemotherapy Market Regional Analysis

6.2 Middle East Cancer Chemotherapy Market Revenue 2021-2031 (US$ Million)
6.3 Middle East Cancer Chemotherapy Market Forecast Analysis

7. Middle East Cancer Chemotherapy Market Analysis – by Therapy Type

7.1 Alkylating Agents
  • 7.1.1 Overview
  • 7.1.2 Alkylating Agents: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Antimetabolites
  • 7.2.1 Overview
  • 7.2.2 Antimetabolites: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Anti-Tumor Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Anti-Tumor Antibiotics: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Topoisomerase Inhibitors
  • 7.4.1 Overview
  • 7.4.2 Topoisomerase Inhibitors: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Mitotic Inhibitors
  • 7.5.1 Overview
  • 7.5.2 Mitotic Inhibitors: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Type
  • 7.6.1 Overview
  • 7.6.2 Other Therapy Type: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East Cancer Chemotherapy Market Analysis – by Indication

8.1 Blood Cancer
  • 8.1.1 Overview
  • 8.1.2 Blood Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
  • 8.2.1 Overview
  • 8.2.2 Lung Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
  • 8.3.1 Overview
  • 8.3.2 Breast Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
  • 8.4.1 Overview
  • 8.4.2 Colorectum Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
  • 8.5.1 Overview
  • 8.5.2 Prostate Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
  • 8.6.1 Overview
  • 8.6.2 Stomach Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
  • 8.7.1 Overview
  • 8.7.2 Cervical Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
  • 8.8.1 Overview
  • 8.8.2 Liver and Intrahepatic Bile Duct Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
  • 8.9.1 Overview
  • 8.9.2 Thyroid Cancer: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
  • 8.10.1 Overview
  • 8.10.2 Other Indications: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East Cancer Chemotherapy Market Analysis – by End User

9.1 Hospital Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospital Pharmacies: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
  • 9.3.1 Overview
  • 9.3.2 Online Stores: Middle East Cancer Chemotherapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East Cancer Chemotherapy Market – Middle East Analysis

10.1 Overview

10.2 Middle East
  • 10.2.1 Middle East Cancer Chemotherapy Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Middle East Cancer Chemotherapy Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Turkiye: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Turkiye: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.1.2 Turkiye: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.1.3 Turkiye: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.2 the United Arab Emirates: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 the United Arab Emirates: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.2.2 the United Arab Emirates: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.2.3 the United Arab Emirates: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.3 Saudi Arabia: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 Saudi Arabia: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.3.2 Saudi Arabia: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.3.3 Saudi Arabia: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.4 Bahrain: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Bahrain: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.4.2 Bahrain: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.4.3 Bahrain: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.5 Oman: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.5.1 Oman: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.5.2 Oman: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.5.3 Oman: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.6 Egypt: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.6.1 Egypt: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.6.2 Egypt: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.6.3 Egypt: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.7 South Africa and Africa: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.7.1 South Africa and Africa: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.7.2 South Africa and Africa: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.7.3 South Africa and Africa: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.8 Algeria: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.8.1 Algeria: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.8.2 Algeria: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.8.3 Algeria: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.9 Nigeria: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.9.1 Nigeria: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.9.2 Nigeria: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.9.3 Nigeria: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.10 Kuwait: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.10.1 Kuwait: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.10.2 Kuwait: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.10.3 Kuwait: Middle East Cancer Chemotherapy Market Breakdown, by End User
  • 10.2.1.11 and Qatar: Middle East Cancer Chemotherapy Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.11.1 and Qatar: Middle East Cancer Chemotherapy Market Breakdown, by Therapy Type
    • 10.2.1.11.2 and Qatar: Middle East Cancer Chemotherapy Market Breakdown, by Indication
    • 10.2.1.11.3 and Qatar: Middle East Cancer Chemotherapy Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Astellas Pharma Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Eli Lilly and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Merck KGaA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Johnson & Johnson
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 AstraZeneca
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pfizer Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Bristol Myers Squibb
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 F. Hoffmann-La Roche Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 AbbVie
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full M Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full M Market Report
205 pages PDF & Excel | 2026-02-19
Download Sample Customization